Endometriosis - Fall 2010
Printer-friendly versionENDOMETRIOSIS
by Judith Fiore, ND
CREATING FAMILIES – FALL 2010 ISSUE
References:
1. Speroff L and Fritz MA. Clinical Gynecologic Endocrinology and Infertility, 7th ed. Philadelphia, Pa.:Lippincott Williams & Wilkins; 2005; chap. 29.
2. Farquhar C., Endometriosis (review). BMJ 2000; 320:1449-52.
3. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Human Reproduction 1991; 6:544-549.
4. Cramer D, Missmer S., Epidemiology of endometriosis. Ann NY Acad Sci 2002; 955:11-22.
5. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. American Journal Obstet Gynecol 1927;14:422-69.
6. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertility Sterility 2001; 1:75.
7. Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis, Ann NY Acad Sci 2002; 955:159.
8. Osteen K, Sierra-Rivera E. Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? Seminars in Reprod Endocrinol 1997; 15(3):301-308.
9. Rier S, Foster WG. Environmental Dioxins and Endometriosis. Toxicological Sciences 2002; 70:161-170.
10. Zeyneloglu H, Arici A, Olive D. Environmental Toxins and Endometriosis. Obstetrics and Gynecology Cinics of North America 1997; 24(2):307-329.
11. Moen MH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand 1993; 72:560.
12. Parazzini F, Chiaffarino F, et al. Selected food intake and risk of endometriosis. Hum Reprod 2004; Aug;19(8):1755-9.
13. Sesti F, Pietropolli A, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial. Fertility and Sterility 2007; 88(6):1541-1547.
14. Rose DP, Lubin M, Connolly JM. Effects of diet supplementation with wheat bran on serum estrogen levels in the follicular and luteal phases of the menstrual cycle. Nutrition 1997;13(6):535-9.
15. Goldin BR, Adlercreutz H, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. The New England Journal of Medicine 1982;307(25):1542-1547.
16. Aguiar FM, Melo SB, et al. Serological testing for celiac disease in women with endometriosis. A pilot study. Clin Exp Obstet Gynecol 2009;36(1):23-5.
17. Ziaei S, Zakeri M, and Kazemnejad A. A randomized controlled trial of Vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005; 112:466-469.
18. Meloni A, Melis M, Alba E, Deiana S. Medical therapy in the management of preterm birth. Journal of Maternal Health. 2009; informahealthcare.com
19. Proctor ML and Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea (Cochrane Review). The Cochrane Database of Systemic Reviews 2001; Issue 2. Art. No.: CD002124.
20. Fontana-Klaiber H and Hogg B. Therapeutic effect of magnesium in dysmenorrhoea. Schweizerische Rundschau fur Medizin Praxis. 1990;79:491-494.
21. Deutch B et al. Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B12 (fish oil or seal oil capsules). Nutrition Research 2000;20:621-631.
22. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006;Apr;65(4):326-31.
23. Sun YZ, Chen HL. Controlled study on Shu-Mu point combination for treatment of endometriosis. Zhongguo Zhen Jiu 2006 Dec;26(12):863-5.
24. Proctor ML, Smith CA, Farquhar CM and Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea (Cochrane Review). The Cochrane Database of Sytematic Reviews 2002, Issue 1. Art. No.:CD002123.
25. Cramer DW, Wilson E, et al. The relation of endometriosis to menstrual characteristics, smoking and exercise. JAMA 1986;255:1904-1908.
26. Perper MM, Breitkopf LJ, et al. Mast scores, alcohol consumption, and gynecologic symptoms in endometriosis patients. Alcohol Clin Exp Res 1993;17:272–78.
27. Matalliotakis IM, Cakmak H, et al. Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet 2008 May;277(5):389-93.
28. Smith G, Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 1996;35:458.
29. Gaytán M, Morales C, Bellido C, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and ovulation: lessons from morphology. Histol Histopathol 2006 May;21(5):541-56.